The local impact of gendercide
Baby girls are being aborted at higher and higher rates around the world. Does that affect how you do business in countries
where this form of gendercide is prevalent?
Health Care
Articles
Ex-Lilly medical director named state health commissioner
Dr. Gregory N. Larkin, the former global medical director at Eli Lilly and Co., will replace Dr. Judy Monroe, who is leaving
to become deputy director of the Centers for Disease Control and Prevention.
IU cancer center names new director
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center’s founding director, who died of cancer in February
2009.
State health commissioner leaving for CDC
Dr. Judy Monroe, after five years as Indiana’s public health leader, will spearhead communication between federal and state
health agencies.
WellPoint records subpoened in California probe
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
Study: Hospital clout spurs higher Calif. health costs
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.
House approves smoking ban in public places
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse
racing venues.
Lilly, Merck, Pfizer starting research center
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
WellPoint gets tax delay in Obama health plan
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
Obama endorses new taxes, more drugmaker fees
Obama, seeking to break an impasse over health-care legislation, proposes a plan that includes the first Medicare tax on unearned
income such as capital gains and higher fees on drugmakers.
Lilly asks shareholders to lower takeover barrier
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
Hamilton County ranked Indiana’s healthiest county
Nationwide report ranks Marion County 87th out of 92 Indiana counties in health factors and 80th in health outcomes.
Clarian, IU plan $100 million neurosciences center
Clarian Health and the Indiana University School of Medicine want their planned neurosciences hub to become a destination
for patients suffering
from brain, nerve and mental maladies—and for the government and industry research dollars that can
fuel advances in care.
Wishard parent ‘ecstatic’ about cheap debt – so far
The Health & Hospital Corporation of Marion County got good news in its first round of borrowing to finance a new Wishard
Hospital: so far, it is paying less than planned.
CVS settles Indiana complaint over 2 pharmacists
Pharmacy giant CVS will pay $1.95 million and verify that all of its pharmacists are licensed in Indiana to settle a state
complaint that pharmacists with expired licenses dispensed prescriptions for several years at two of its drugstores.
Owners, developers see silver lining in health care real estate
Health care real estate has survived the nation’s weak economy better than most sectors, and some owners and developers
think it’s positioned to thrive.
Cardinal Health laying off 49 at local warehouse
Cardinal Health notified the state on Feb. 3 that it laid off 37 workers at the end of January and plans to lay off 12 more
effective April 3.
Underrated entrepreneurs
The Indianapolis area is home to myriad unsung entrepreneurs who run interesting companies, make money and create good jobs.
Here are some of them.
Indy without Lilly, the 500?
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.